甲基3-氨基-4-(丙基氨基)苯甲酸酯 | 762295-22-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 甲基3-氨基-4-(丙基氨基)苯甲酸酯
• 英文名称: methyl 3-amino-4-(propylamino)benzoate
• CAS: 762295-22-7
• 化学式: C₁₁H₁₆N₂O₂
• 分子量: 208.26
• InChiKey: ICPJPXAGTCJEDK-UHFFFAOYSA-N

物化性质

• 沸点：
  369.1±32.0 °C(Predicted)
• 密度：
  1.143±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  64.4
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 海关编码：
  2922499990

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Methyl 3-amino-4-(propylamino)benzoate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Methyl 3-amino-4-(propylamino)benzoate
CAS number: 762295-22-7

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C11H16N2O2
Molecular weight: 208.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  甲基3-氨基-4-(丙基氨基)苯甲酸酯 在 盐酸 、 1-羟基苯并三唑 、 对甲苯磺酸 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 三乙胺 作用下， 以 甲醇 、 二氯甲烷 、 水 为溶剂， 反应 11.0h， 生成 methyl 2-(6-chloro-2-oxo-2H-chromen-3-yl)-1-propyl-1H-benzo[d]imidazole-5-carboxylate
  参考文献：
  名称：

  一锅，三步，分子内Knoevenagel环化的香豆素连接的苯并咪唑的多样性为导向的合成。

  摘要：

  N-（2-氨基苯基）-2-氰基乙酰胺通过一锅三步顺序反应以优异的收率实现了香豆素连接的苯并咪唑的多样性导向合成。氰基乙酰胺的原位分子内环化得到苯并咪唑，随后使2-氰基甲基苯并咪唑与三乙胺促进的水杨醛进行Knoevenagel缩合反应以达到目标化合物。的重要中间体，2-（2-亚氨基-2- ħ -苯并吡喃-3-基）-1 ħ -苯并咪唑用X射线分析，并进一步水解为2-（香豆素-3-基）苯并咪唑在酸性条件下。在合成的化合物中，发现有一些是猪肾d-氨基酸氧化酶（pk DAO）。

  DOI：

  10.1021/acscombsci.7b00004
• 作为产物：
  描述：

  methyl 3-nitro-N⁴-propylaminobenzoate 在 palladium on activated charcoal 、 氢气 作用下， 以 甲醇 、 乙酸乙酯 为溶剂， 20.0 ℃ 、100.0 kPa 条件下， 生成 甲基3-氨基-4-(丙基氨基)苯甲酸酯
  参考文献：
  名称：

  2-氨基苯并咪唑用于利什曼病：从最初的发现到体内分析。

  摘要：

  利什曼病是一种主要的传染病，每年有成千上万的新病例，死亡人数超过20,000。当前用于治疗这种威胁生命的感染的药物具有一些缺点，例如毒性和长期的治疗方案。作为优化计划的一部分，针对婴儿利什曼原虫筛选了180万种化合物的库，可以从此处公开报道点击率。发现具有2-氨基苯并咪唑官能度的化合物具有中等效力，低代谢稳定性和高亲脂性。进行了几轮合成以结合能够降低亲脂性和清除率的化学基团，从而鉴定出对不同寄生虫菌株具有活性并具有改进的体外特性的化合物。这项优化计划的结果是，为了预期体内评估，进一步测试了一组化合物。用化合物29（婴儿乳IC50：4.1μM）和39（婴儿乳IC50：0.5μM）在急性婴儿VL小鼠模型中进行了体内测试，结果显示暴露不良且缺乏功效的问题，尽管具有良好的体外效能。

  DOI：

  10.1371/journal.pntd.0009196

文献信息

• 2-aminobenzimidazoles for leishmaniasis: From initial hit discovery to in vivo profiling
  作者：Rafael Augusto Alves Ferreira、Celso de Oliveira Rezende Junior、Pablo David Grigol Martinez、Paul John Koovits、Bruna Miranda Soares、Leonardo L. G. Ferreira、Simone Michelan-Duarte、Rafael Consolin Chelucci、Adriano D. Andricopulo、Mariana K. Galuppo、Silvia R. B. Uliana、An Matheeussen、Guy Caljon、Louis Maes、Simon Campbell、Jadel M. Kratz、Charles E. Mowbray、Luiz Carlos Dias

  DOI：10.1371/journal.pntd.0009196

  日期：——

  treatment regimens. A library of 1.8 million compounds, from which the hits reported here are publicly available, was screened against Leishmania infantum as part of an optimization program; a compound was found with a 2-aminobenzimidazole functionality presenting moderate potency, low metabolic stability and high lipophilicity. Several rounds of synthesis were performed to incorporate chemical groups

  利什曼病是一种主要的传染病，每年有成千上万的新病例，死亡人数超过20,000。当前用于治疗这种威胁生命的感染的药物具有一些缺点，例如毒性和长期的治疗方案。作为优化计划的一部分，针对婴儿利什曼原虫筛选了180万种化合物的库，可以从此处公开报道点击率。发现具有2-氨基苯并咪唑官能度的化合物具有中等效力，低代谢稳定性和高亲脂性。进行了几轮合成以结合能够降低亲脂性和清除率的化学基团，从而鉴定出对不同寄生虫菌株具有活性并具有改进的体外特性的化合物。这项优化计划的结果是，为了预期体内评估，进一步测试了一组化合物。用化合物29（婴儿乳IC50：4.1μM）和39（婴儿乳IC50：0.5μM）在急性婴儿VL小鼠模型中进行了体内测试，结果显示暴露不良且缺乏功效的问题，尽管具有良好的体外效能。
• Copper catalyzed aerobic oxidative cyclization and ketonization: one pot synthesis of benzoimidazo[1,2-a]imidazolones
  作者：Manikandan Selvaraju、Tzuen-Yang Ye、Chia-Hsin Li、Pei-Heng Ho、Chung-Ming Sun

  DOI：10.1039/c6cc01828a

  日期：——

  A highly efficient synthesis of benzoimidazo[1,2-a]imidazolone through a novel oxidative 5-exo-dig cyclization-ketonization cascade of 2-aminobenzimidazole, aldehyde and terminal alkyne has been explored under aerobic conditions.

  在有氧条件下，通过2-氨基苯并咪唑，醛和末端炔的新型5 - exo -dig环化-酮化级联反应，高效合成了苯并咪唑并[1,2- a ]咪唑酮。
• A concise synthesis of 2-(2-aminothiophene)-benzimidazoles by one-pot multicomponent reaction
  作者：Li-Hsun Chen、Ying-Sheng Chuang、Bharat D. Narhe、Chung-Ming Sun

  DOI：10.1039/c3ra41545g

  日期：——

  A one-pot synthesis of 2-aminothiophene linked benzimidazoles was achieved by utilizing 2-cyanomethyl benzimidazoles in a modified Gewald multicomponent reaction. The synthetic strategy of the reaction involved treatment of 2-(cyanomethyl)-benzimdazole with aldehydes containing an active methylene group and sulfur powder under refluxing conditions. The multicomponent reaction proceeded via Knoevenagel condensation of 2-(cyanomethyl)-benzimdazole with aldehyde to generate an α,β-unsaturated nitrile followed by cyclization with molecular sulfur under basic conditions to give biologically relevant 2-(2-aminothiophene)-benzimidazoles in good yields.

  通过在改进的 Gewald 多组分反应中利用 2-氰甲基苯并咪唑，实现了 2-氨基噻吩连接的苯并咪唑的一锅法合成。该反应的合成策略是在回流条件下用含有活性亚甲基的醛和硫粉处理2-(氰甲基)-苯并咪唑。该多组分反应通过 2-(氰甲基)-苯并咪唑与醛的 Knoevenagel 缩合进行，生成 α,β-不饱和腈，然后在碱性条件下与分子硫环化，得到生物相关的 2-(2-氨基噻吩)-苯并咪唑。产量。
• WO2007/69053
  申请人：——

  公开号：——

  公开（公告）日：——
• Synthesis and bioevaluation of pyrazole-benzimidazolone hybrids as novel human 4-Hydroxyphenylpyruvate dioxygenase inhibitors
  作者：Yu-Ling Xu、Hong-Yan Lin、Xu Ruan、Sheng-Gang Yang、Ge-Fei Hao、Wen-Chao Yang、Guang-Fu Yang

  DOI：10.1016/j.ejmech.2015.01.018

  日期：2015.3

  4-Hydroxyphenylpyruvate dioxygenase (HPPD), an essential enzyme in tyrosine catabolism, is an important target for treating type I tyrosinemia. Inhibition of HPPD can effectively alleviate the symptoms of type I tyrosinemia. However, only one commercial HPPD inhibitor, 2-(2-nitro-4-trifluoromethylbenzoyl) cyclohexane-1,3-dione (NTBC), has been available for clinical use so far. In the present study, a series of novel pyrazole-benzimidazolone hybrids were designed, synthesized and evaluated as potent human HPPD inhibitors. Most of the new compounds displayed significant inhibitory activity against the recombinant human HPPD. Moreover, compound 91 was identified as the most potent candidate with IC50 value of 0.021 mu M against recombinant human HPPD, about 3-fold more potent than NTBC. Thus the pyrazole-benzimidazolone hybrid has great potential to be further developed for the treatment of type I tyrosinemia. (C) 2015 Elsevier Masson SAS. All rights reserved.